Home/Pipeline/Chronic Pain Program

Chronic Pain Program

Chronic pain

ResearchActive

Key Facts

Indication

Chronic pain

Phase

Research

Status

Active

Company

Current Surgical

About Current Surgical

Current Surgical is a private, pre-revenue medical device startup founded in 2016, building a foundational platform for the next generation of minimally invasive, digital surgery. Its core technology integrates AI-processed real-time imaging with precision focused ultrasound ablation in a closed-loop control system, initially targeting early-stage solid tumor ablation. The company has a clear multi-year pipeline to expand into cardiac, pain, and neurological markets, is backed by elite investors like True Ventures, and has secured non-dilutive funding from the NIH and NSF to advance its platform.

View full company profile

Therapeutic Areas

Oncology Cardiology Neurology Pain Management

Other Chronic pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active
Platform Enhancements	Nevro	R&D	Active